Core Viewpoint - The Shenzhen-Hong Kong Stock Connect Medical Index (983036) closed at 4375.4 points on November 25, with a 0.52% increase and a trading volume of 8.459 billion HKD, indicating a positive market sentiment in the healthcare sector [1]. Group 1: Index Performance - The index had 40 stocks rising and 16 stocks falling on the day, with Ping An Good Doctor leading the gainers at a 4.27% increase, while Ruimaite led the decliners with a 1.98% drop [1]. - The index's turnover rate was 0.84%, reflecting moderate trading activity [1]. Group 2: Component Stocks Details - The top ten component stocks of the index include: - Mindray Medical (14.56% weight, 193.88 HKD, 0.46% increase, market cap 235.068 billion HKD) [1] - Yeye Eye Hospital (11.62% weight, 11.59 HKD, 0.35% increase, market cap 108.081 billion HKD) [1] - Lejin Medical (4.85% weight, 15.80 HKD, 0.45% increase, market cap 29.126 billion HKD) [1] - Aimeike (4.80% weight, 145.54 HKD, -0.31% decrease, market cap 44.039 billion HKD) [1] - Yuyue Medical (4.66% weight, 35.67 HKD, -0.14% decrease, market cap 35.758 billion HKD) [1] - Yingke Medical (3.64% weight, 40.26 HKD, 0.20% increase, market cap 26.362 billion HKD) [1] - Furuishi (3.59% weight, 65.75 HKD, -1.50% decrease, market cap 17.422 billion HKD) [1] - Meinian Health (3.58% weight, 5.42 HKD, 0.74% increase, market cap 21.215 billion HKD) [1] - Sinopharm (3.35% weight, 18.55 HKD, 0.49% increase, market cap 57.888 billion HKD) [1] - Ping An Good Doctor (2.63% weight, 13.33 HKD, 4.27% increase, market cap 28.822 billion HKD) [1]. Group 3: Capital Flow - The net outflow of main funds from the index's component stocks totaled 251 million HKD, while retail investors saw a net inflow of 199 million HKD [1]. - The detailed capital flow indicates that while main funds were withdrawing, retail investors were actively buying into the market [2]. Group 4: Recent Adjustments - In the last 10 days, the index underwent adjustments, adding one new stock, Jianfa Zhixin, which is in the medical biology sector with a market cap of 13.886 billion HKD [3].

Core Viewpoint - The Shenzhen-Hong Kong Medical Index (983035) closed at 4488.12 points on November 25, with a 0.45% increase and a trading volume of 7.719 billion yuan, indicating a stable performance in the healthcare sector [1]. Group 1: Index Performance - On the same day, 40 out of the index's constituent stocks rose, with Ping An Good Doctor leading the gains at 4.27%, while 16 stocks declined, with Ruimaite leading the losses at 1.98% [1]. - The top ten constituent stocks of the Shenzhen-Hong Kong Medical Index include: - Mindray Medical (14.56% weight, market cap 235.068 billion yuan) [1] - Yier Eye Hospital (11.62% weight, market cap 108.081 billion yuan) [1] - Lejin Medical (4.85% weight, market cap 29.126 billion yuan) [1] - Aimeike (4.80% weight, market cap 44.039 billion yuan) [1] - Yuyue Medical (4.66% weight, market cap 35.758 billion yuan) [1] - Yingke Medical (3.64% weight, market cap 26.362 billion yuan) [1] - Furuishi (3.59% weight, market cap 17.422 billion yuan) [1] - Meinian Health (3.58% weight, market cap 21.215 billion yuan) [1] - China National Pharmaceutical (3.35% weight, market cap 57.888 billion yuan) [1] - Ping An Good Doctor (2.63% weight, market cap 28.822 billion yuan) [1]. Group 2: Capital Flow - The net outflow of main funds from the constituent stocks totaled 251 million yuan, while retail investors saw a net inflow of 199 million yuan [3]. - The detailed capital flow for selected stocks includes: - Aimeike: Main net inflow of 23.5405 million yuan, retail net outflow of 35.0461 million yuan [3]. - New Mileage: Main net inflow of 14.1523 million yuan, retail net outflow of 6.6983 million yuan [3]. - Jianfan Biological: Main net inflow of 4.5525 million yuan, retail net outflow of 8.5385 million yuan [3]. - A total of one stock was newly added to the Shenzhen-Hong Kong Medical Index in the last ten days [4].

Core Insights - The launch of the Invesco Great Wall ChiNext 50 ETF Depository Receipts (DR) on the Thailand Stock Exchange marks the first time a Chinese A-share ETF has been listed in Thailand, indicating a significant step for Chinese core technology assets entering the Southeast Asian market [1][2] - The ChiNext 50 Index has been expanding internationally, having previously been listed on major European exchanges, and aims to enhance the internationalization of ChiNext products [2][3] Market Demand for Chinese Core Assets - There is a rapidly increasing demand from Thai investors for Chinese core assets, driven by China's high-quality economic development and capital market reforms [3] - The collaboration between Invesco and InnovestX, a leading Thai brokerage, facilitates direct trading of the ChiNext 50 Index for Thai investors [3] Rationale for Choosing ChiNext 50 Index - The ChiNext 50 Index focuses on high-tech industries such as new energy, advanced manufacturing, and biomedicine, making it an attractive investment for Thai investors looking to capture the benefits of China's technological advancements [4] - Familiarity with leading companies like CATL among Thai investors enhances trust in the new ChiNext 50 ETF DR product [4] Performance and Liquidity of ChiNext 50 Index - The ChiNext 50 Index has shown strong performance, with a cumulative increase of 56.49% as of November 18, outperforming other broad-based indices [5][6] - The index consists of the 50 largest and most actively traded companies on the ChiNext, providing excellent liquidity and making it an ideal target for long-term and large-scale investments [5] Earnings Performance of Index Constituents - The earnings performance of the ChiNext 50 Index constituents has been robust, with an average revenue growth rate of 21.07% and a net profit growth rate of 16.63% reported in the mid-year results [7] - The top ten weighted stocks in the index have shown even more impressive growth, with an average revenue growth of 48.93% and a net profit growth of 82.03% [7] Industry Composition of ChiNext 50 Index - The ChiNext 50 Index is characterized by a high concentration of technology-focused companies, excluding traditional cyclical industries, and primarily includes firms in new energy vehicles, biomedicine, electronics, photovoltaic, and internet finance [8][9] - The index's top three weighted industries are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [8] Global Integration and Competitive Advantage - The ChiNext aims to support innovative enterprises in sectors with international competitiveness, thereby enhancing the global value chain [9] - In 2024, the ChiNext 50 Index's overseas business revenue accounted for 35.17% of total revenue, indicating a strong international presence compared to other major indices [9]

Core Viewpoint - The company, Yingte Group, confirmed its collaboration with several medical device suppliers, including Mindray Medical, in response to an investor inquiry on an interactive platform [1]. Group 1 - Yingte Group is primarily engaged in the wholesale and retail business of pharmaceuticals and medical devices [1]. - The company has business cooperation with multiple suppliers in the medical device sector, indicating a diversified supplier network [1].

Core Viewpoint - The successful listing of the Invesco Great Wall ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks a significant step for Chinese core technology assets entering the Southeast Asian market, enhancing Sino-Thai financial cooperation [2][4]. Group 1: Market Expansion - This is the first time a Chinese A-share listed ETF has been launched in Thailand via depository receipts, representing a new product for the Thai market [2]. - The ChiNext 50 Index has been expanding internationally, having previously listed in major European exchanges [2]. - The Shenzhen Stock Exchange is committed to internationalizing ChiNext products, aiming to create a cross-border trading ecosystem for these ETFs [2][4]. Group 2: Investment Demand - There is a rapidly increasing demand from Thai investors for Chinese core assets, driven by China's high-quality economic development and capital market reforms [4]. - The collaboration between Invesco and local issuer InnovestX aims to provide Thai investors with direct access to the ChiNext 50 Index [4]. Group 3: Index Characteristics - The ChiNext 50 Index focuses on high-tech sectors such as new energy, advanced manufacturing, and biomedicine, making it an attractive investment for capturing China's technological growth [6]. - The index has shown strong liquidity and market performance, with a year-to-date increase of 51.58% and a cumulative increase of 56.49% as of November 18 [7][8]. Group 4: Performance Metrics - The average revenue growth rate for the ChiNext 50 Index constituents was 21.07% in the mid-2025 reporting season, with a net profit growth rate of 16.63% [9]. - The top ten weighted stocks in the index demonstrated significant growth, with an average revenue growth of 48.93% and a net profit growth of 82.03% [9]. - The index excludes traditional cyclical industries, focusing instead on high-tech sectors, which enhances its technological concentration [10]. Group 5: Industry Insights - The ChiNext 50 Index is positioned to support innovative enterprises in sectors like power batteries and photovoltaic inverters, which have international competitiveness [11]. - The overseas revenue proportion for the ChiNext 50 Index is 35.17%, indicating strong global market integration [11].

Core Insights - The successful listing of the Invesco Great Wall ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks the first time a Chinese A-share ETF has been listed in Thailand, enhancing financial cooperation between China and Thailand [1][2] - The demand for investment in Chinese core assets is rapidly increasing among Thai investors, driven by China's high-quality economic development and capital market reforms [2][3] - The ChiNext 50 Index focuses on high-tech industries such as new energy, advanced manufacturing, and biomedicine, making it an attractive investment for Thai investors looking to capture the benefits of China's technological advancements [3][4] Market Performance - The ChiNext 50 Index has shown strong performance, with a cumulative increase of over 51% as of November 18, outperforming other broad-based indices [3][4] - The average revenue growth rate for the index's constituent stocks was 21.07% year-on-year in the mid-2025 reporting season, with net profit growth at 16.63% [4] - In the third quarter, the revenue growth rate for the constituent stocks remained robust at 15.75%, while net profit growth increased to 22.58% [4] Sector Analysis - The ChiNext 50 Index is heavily weighted towards high-growth sectors, with significant representation from batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [5] - The index's top ten constituent stocks have shown exceptional growth, with an average revenue growth rate of 48.93% and net profit growth of 82.03% [4][5] - The index aims to support innovative enterprises in sectors with international competitiveness, contributing to the global value chain and enhancing the performance of ChiNext 50 companies [5]

Core Viewpoint - The listing of the ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks a significant milestone in the internationalization of China's capital markets, providing Thai investors with direct access to China's core technology assets [2][3]. Group 1: Internationalization of ChiNext 50 ETF - The ChiNext 50 ETF Depository Receipts were listed on November 25, providing Thai investors with a new investment product focused on the ChiNext 50 Index [2][3]. - This is the first time a Chinese A-share listed ETF has been issued in Thailand in the form of Depository Receipts, indicating a growing interest in Chinese technology assets in Southeast Asia [2][3]. - The Shenzhen Stock Exchange aims to enhance the internationalization of the ChiNext market and facilitate global investors in sharing the benefits of China's technological innovation [2][3]. Group 2: Market Demand and Product Details - The demand for investment in Chinese core assets among Thai investors has surged, driven by China's high-quality economic development and capital market reforms [3]. - The Invesco China ChiNext 50 ETF, established in December 2022, has surpassed 50 billion in total assets and maintains a low fee structure of 0.2% [3][4]. - InnovestX, a leading Thai brokerage, partnered with Invesco to issue the Depository Receipts, enhancing the accessibility of the ChiNext 50 Index for local investors [3][4]. Group 3: Performance of ChiNext 50 Index - As of November 18, the ChiNext 50 Index has shown a cumulative increase of 56.49% this year, outperforming other broad-based indices [5]. - The average revenue growth rate for the ChiNext 50 constituent stocks was 21.07% year-on-year for the mid-year report, with net profit growth at 16.63% [5]. - In the third quarter, the revenue growth rate remained strong at 15.75%, while net profit growth increased to 22.58% [5]. Group 4: Sector Focus and Composition - The ChiNext 50 Index focuses on high-tech sectors such as new energy, advanced manufacturing, and biomedicine, making it an attractive investment for capturing China's technological development [4][6]. - The index excludes traditional cyclical industries, emphasizing a higher concentration of technology stocks, with significant weights in battery, communication equipment, and photovoltaic sectors [6]. - The top three sectors by weight in the ChiNext 50 Index are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [6]. Group 5: Global Integration and Revenue - The leading companies in the ChiNext are deeply integrated into the global value chain, with 35.17% of their revenue coming from overseas markets in 2024, which is higher than many major broad-based indices [7]. - The average overseas revenue proportion for the top ten weighted stocks in the ChiNext 50 Index is 47.96%, indicating strong international market engagement [7].

Core Viewpoint - The listing of the Invesco Great Wall ChiNext 50 ETF Depository Receipts on the Thailand Stock Exchange marks a significant milestone in the internationalization of China's ChiNext index, providing Thai investors with direct access to China's core technology assets [3][4]. Group 1: Internationalization of ChiNext Index - The ChiNext 50 ETF Depository Receipts are the first of their kind from China's A-share market to be listed in Thailand, enhancing the international presence of the ChiNext index [3][4]. - The Shenzhen Stock Exchange aims to leverage this listing to further internationalize the ChiNext investment platform and facilitate global investors' access to China's technological innovations [3][4]. Group 2: Market Demand and Product Details - There is a growing demand among Thai investors for investment products related to China's core assets, driven by China's high-quality economic development and capital market reforms [4]. - The Invesco Great Wall ChiNext 50 ETF was established in December 2022 and currently has a total scale exceeding 50 billion, with a low fee structure of 0.2% [4][5]. Group 3: Performance of ChiNext 50 Index - As of November 18, 2025, the ChiNext 50 Index has shown a cumulative increase of 56.49%, outperforming other broad-based indices [6]. - The index's constituent stocks reported an average revenue growth of 21.07% and a net profit growth of 16.63% in the first half of 2025, with continued strong performance in the third quarter [6][7]. Group 4: Sector Focus and Composition - The ChiNext 50 Index focuses on high-tech sectors such as new energy, advanced manufacturing, and biomedicine, capturing the benefits of China's technological advancements [5][8]. - The top three sectors by weight in the ChiNext 50 Index are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [8]. Group 5: Global Integration and Revenue - The leading companies in the ChiNext 50 Index are deeply integrated into the global value chain, with 35.17% of their revenue coming from overseas markets in 2024, which is higher than many broad-based indices [8]. - The average overseas revenue proportion for the top ten weighted stocks in the index is 47.96%, indicating a strong international market presence [8].

Core Viewpoint - The launch of the ChiNext 50 Index Depository Receipts (DRs) on the Thailand Stock Exchange marks a significant milestone in the internationalization of the ChiNext 50 Index, providing Thai investors with direct access to China's core technology assets [1][2]. Group 1: Internationalization of ChiNext 50 Index - The ChiNext 50 Index has successfully expanded internationally, having previously listed on major European exchanges and now entering the Thai market [1]. - The listing of the ChiNext 50 ETF DRs is the first of its kind for A-share ETFs in Thailand, symbolizing the entry of Chinese core technology assets into the Southeast Asian market [1][2]. - The Shenzhen Stock Exchange aims to enhance the internationalization of the ChiNext market and facilitate global investors' access to China's technological innovations [1]. Group 2: Market Demand and Product Details - There is a growing demand among Thai investors for investment products related to Chinese core assets, driven by China's high-quality economic development and capital market reforms [2]. - The ChiNext 50 ETF, established in December 2022, has an overall scale exceeding 50 billion, with a low fee structure of 0.2% [2]. - InnovestX, a leading Thai brokerage, collaborates with Invesco to issue the DRs, which can be traded like stocks on the exchange [2]. Group 3: Performance of ChiNext 50 Index - As of November 18, the ChiNext 50 Index has shown a cumulative increase of 56.49%, outperforming other broad-based indices [4]. - The index's constituent stocks reported an average revenue growth of 21.07% and a net profit growth of 16.63% in the mid-year report for 2025 [4]. - In the third quarter, the revenue growth for the constituent stocks remained strong at 15.75%, with net profit growth rising to 22.58% [4]. Group 4: Key Constituents and Sector Focus - The top ten weighted stocks in the ChiNext 50 Index include leading companies such as CATL and Mindray, with an average revenue growth of 48.93% and net profit growth of 82.03% [5]. - The index focuses on high-tech sectors such as new energy, high-end manufacturing, and biomedicine, reflecting a higher concentration of technology compared to traditional industries [5][6]. - The three largest weighted sectors in the ChiNext 50 Index are batteries (29.76%), communication equipment (18.62%), and photovoltaic equipment (8.22%) [6].

Core Viewpoint - The article reports on the performance of the Chuangye 50 ETF (159682), highlighting its increase of 2.76% as of the midday close on November 25, with a trading volume of 279 million yuan [1] Group 1: ETF Performance - Chuangye 50 ETF (159682) closed at 1.379 yuan, with a trading volume of 2.79 billion yuan [1] - The ETF's performance benchmark is the return rate of the ChiNext 50 Index [1] - Since its establishment on December 23, 2022, the fund has achieved a return of 34.32%, while its return over the past month has been -8.44% [1] Group 2: Top Holdings - Key stocks in the Chuangye 50 ETF include: - Ningde Times, up 1.35% - Zhongji Xuchuang, up 6.06% - Dongfang Wealth, up 0.51% - Xinyi Sheng, up 6.03% - Sunshine Power, up 5.87% - Shenghong Technology, up 6.15% - Huichuan Technology, up 1.35% - Mindray Medical, up 0.73% - Yiwei Lithium Energy, up 1.82% - Tonghuashun, up 0.73% [1]